NCT02163408View on ClinicalTrials.gov

3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery

CompletedOBSERVATIONAL
Enrollment

134

Participants

Timeline

Start Date

June 24, 2014

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions
Carotid Artery Disease
Interventions
OTHER

MRI with/without contrast

Bilateral carotid plaque imaging at 3.0T. Conventional MRI scans with T1-, T2-weightings and scans using the developed techniques. MR contrast may be used in conventional protocol when it is needed to evaluate the performance of the developed techniques

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

American Heart Association

OTHER

lead

Cedars-Sinai Medical Center

OTHER

NCT02163408 - 3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery | Biotech Hunter | Biotech Hunter